Predictive value of NRI, NLR, PLR and LMR for therapeutic efficacy and prognosis in advanced rectal cancer patients treated with PD-1/PD-L1 immunotherapy - Quiz - MDSpire

Predictive value of NRI, NLR, PLR and LMR for therapeutic efficacy and prognosis in advanced rectal cancer patients treated with PD-1/PD-L1 immunotherapy

  • By

  • Mengli Gao

  • Zhe Gao

  • Yanan Wang

  • Wenguang Song

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Predictive value of NRI, NLR, PLR and LMR for therapeutic efficacy and prognosis in advanced rectal cancer patients treated with PD-1/PD-L1 immunotherapy

  • by Mengli Gao, Zhe Gao, Yanan Wang, Wenguang Song

  • May 28, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer